EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and biological evaluation of selective cytotoxicity-derived Miliusol derivatives inducing profound TNBC regression in vivo

Xiaoling Cheng, Weiji Chen, Wenli Hao, Yaping Guo, Jin Zhang, Chao Song, Zhendan He, Haiqiang Wu, Dahong Yao

Bioorganic & Medicinal Chemistry · 2026-07 · 138 · 118680

DOI: 10.1016/j.bmc.2026.118680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2026-07. Verfasst von Xiaoling Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Applied Sciences, Shenzhen University, Shenzhen 518060, China.; Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imagin…. Hauptthemen laut MEDLINE: Drug Design, Antineoplastic Agents, Triple Negative Breast Neoplasms. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Shenzhen Hospital of Southern Medical University, Shenzhen Science and Technology Innovation Committee, Guangdong Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) remains a challenging malignancy due to its aggressive nature and lack of targeted therapies. Miliusol, a natural product isolated from Miliusa tenuistipitata, exhibits potent anti-proliferative activity against TNBC but suffers from non-selective cytotoxicity. In this study, we employed a selective cytotoxicity-guided strategy to design and synthesize two novel series of Miliusol derivatives. MM-13 displayed enhanced tumor-selective cytotoxicity and demonstrated superior anti-proliferative and anti-migratory effects in TNBC cell lines compared to Miliusol, while showing minimal toxicity toward non-tumorigenic MCF-10A cells. Mechanistic studies revealed that MM-13 could inhibit glycolysis and induce DNA damage and apoptosis via the AKT/mTOR pathway. Importantly, MM-13 significantly suppressed tumor growth and metastasis in a 4T1 murine model without observable systemic toxicity. Our findings have enhanced the structure-activity relationship of Miliusol-type compounds and identify MM-13 as a promising candidate for TNBC-targeted therapy, offering a rational approach for improving natural product-derived anticancer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignAntineoplastic AgentsTriple Negative Breast NeoplasmsHumansAnimalsStructure-Activity RelationshipCell ProliferationMiceFemaleApoptosisDrug Screening Assays, AntitumorMolecular StructureCell Line, TumorMice, Inbred BALB CDose-Response Relationship, Drug

Stichwörter der Autor:innen

MetastasisMiliusolProliferationTNBCToxicity

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • College of Applied Sciences, Shenzhen University, Shenzhen 518060, China.; Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical…
  • College of Applied Sciences, Shenzhen University, Shenzhen 518060, China.
  • College of Applied Sciences, Shenzhen University, Shenzhen 518060, China.; School of Pharmaceutical Sciences, Shenzhen Technology University, Shenzhen 518118, China.
  • College of Applied Sciences, Shenzhen University, Shenzhen 518060, China.; Anning First People's Hospital Affiliated to Kunming University of Science and Technology, China.
  • College of Applied Sciences, Shenzhen University, Shenzhen 518060, China.; School of Pharmaceutical Sciences, Shenzhen Technology University, Shenzhen 518118, China. Electronic address: hezhendan@sztu.edu.cn.
  • College of Applied Sciences, Shenzhen University, Shenzhen 518060, China.; School of Pharmaceutical Sciences, Shenzhen Technology University, Shenzhen 518118, China. Electronic address: yaodahong@sztu.edu.cn.

Förderung

  • Shenzhen Hospital of Southern Medical University
  • Shenzhen Science and Technology Innovation Committee
  • Guangdong Provincial Natural Science Foundation
  • Shenzhen Science and Technology Innovation Program
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Shenzhen University
  • National Natural Science Foundation of China

Zitieren

APA

Cheng, X., Chen, W., Hao, W., Guo, Y., Zhang, J., Song, C., He, Z., Wu, H., & Yao, D. (2026). Design, synthesis, and biological evaluation of selective cytotoxicity-derived Miliusol derivatives inducing profound TNBC regression in vivo. Bioorganic & Medicinal Chemistry, 138, 118680. https://doi.org/10.1016/j.bmc.2026.118680

Vancouver

Cheng X, Chen W, Hao W, Guo Y, Zhang J, Song C, et al. Design, synthesis, and biological evaluation of selective cytotoxicity-derived Miliusol derivatives inducing profound TNBC regression in vivo. Bioorganic & Medicinal Chemistry. 2026;138:118680. doi:10.1016/j.bmc.2026.118680

BibTeX
@article{Cheng2026,
  author = {Cheng, Xiaoling and Chen, Weiji and Hao, Wenli and Guo, Yaping and Zhang, Jin and Song, Chao and He, Zhendan and Wu, Haiqiang and Yao, Dahong},
  title = {Design, synthesis, and biological evaluation of selective cytotoxicity-derived Miliusol derivatives inducing profound TNBC regression in vivo},
  journal = {Bioorganic & Medicinal Chemistry},
  year = {2026},
  volume = {138},
  pages = {118680},
  doi = {10.1016/j.bmc.2026.118680}
}
Kostenlos starten →